![Shenzhen Hepalink Pharmaceutical Group Co., Ltd. logo](/logos/002399.SZ.webp)
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SZSE:002399.SZ
Overview | Financials
Company Name | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. |
Symbol | 002399.SZ |
Currency | CNY |
Price | 11.65 |
Market Cap | 15,340,136,591 |
Dividend Yield | 0.99% |
52-week-range | 10.98 - 15.64 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Li Li |
Website | https://www.hepalink.com |
An error occurred while fetching data.
About Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished dose pharmaceutical products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD